CAS Medical Systems, Inc. Release: New Study Shows Superior Accuracy of FORE-SIGHT Oximetry

BRANFORD, Conn., Oct. 27, 2011 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) today announced the presentation of a comparative study showing the superior accuracy of its FORE-SIGHT® Absolute Tissue Oximeter against other available oximeters. The study, led by Dr. Philip E. Bickler at the world renowned Hypoxia Research Laboratory at the University of California, San Francisco, was the first of its kind and was presented at last week's annual meeting of the American Society of Anesthesiologists (ASA) in Chicago, IL.
MORE ON THIS TOPIC